Published in Exp Physiol on March 19, 2010
Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension. Hypertension (2011) 1.48
Influence of age and sex on the pressor response following a spontaneous burst of muscle sympathetic nerve activity. Am J Physiol Heart Circ Physiol (2012) 1.18
c-Src in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats. Pflugers Arch (2011) 0.85
Neuroimmune communication in hypertension and obesity: a new therapeutic angle? Pharmacol Ther (2013) 0.85
SOD1 gene transfer into paraventricular nucleus attenuates hypertension and sympathetic activity in spontaneously hypertensive rats. Pflugers Arch (2012) 0.83
Essential hypertension: an approach to its etiology and neurogenic pathophysiology. Int J Hypertens (2013) 0.81
Pharmacological studies of tentacle extract from the jellyfish Cyanea capillata in isolated rat aorta. Mar Drugs (2013) 0.81
Angiotensin-(1-7) in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats. PLoS One (2012) 0.80
Pivotal role of α2 Na(+) pumps and their high affinity ouabain binding site in cardiovascular health and disease. J Physiol (2016) 0.79
Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension. Curr Hypertens Rep (2013) 0.78
Effect of simvastatin in the autonomic system is dependent on the increased gain/sensitivity of the baroreceptors. Physiol Rep (2013) 0.78
Mechanisms and therapeutic potential of microRNAs in hypertension. Drug Discov Today (2015) 0.78
Blood pressure regulation XI: overview and future research directions. Eur J Appl Physiol (2014) 0.77
Angiotensin II and angiotensin-(1-7) in paraventricular nucleus modulate cardiac sympathetic afferent reflex in renovascular hypertensive rats. PLoS One (2012) 0.77
A mechanism-based approach to prevention of and therapy for fibromyalgia. Pain Res Treat (2011) 0.75
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
Point: cardiovascular variability is/is not an index of autonomic control of circulation. J Appl Physiol (1985) (2006) 11.52
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53
Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation (1999) 8.92
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation (2008) 5.26
Greater cardiovascular responses to laboratory mental stress are associated with poor subsequent cardiovascular risk status: a meta-analysis of prospective evidence. Hypertension (2010) 4.62
Shattuck Lecture. The hypertension paradox--more uncontrolled disease despite improved therapy. N Engl J Med (2009) 4.16
Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res (2000) 3.60
Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med (2009) 2.97
Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation (1997) 2.49
Persistent sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term morbidity? Hypertension (2005) 2.48
Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol (1992) 1.97
Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet (1953) 1.95
Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension (1999) 1.82
The influence of low job control on ambulatory blood pressure and perceived stress over the working day in men and women from the Whitehall II cohort. J Hypertens (2004) 1.80
Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study. Hypertension (2008) 1.76
Newly reported hypertension after military combat deployment in a large population-based study. Hypertension (2009) 1.76
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res (2003) 1.67
Atorvastatin reduces sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolaemia and systemic arterial hypertension. Kardiol Pol (2009) 1.48
Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion. J Hypertens (2004) 1.46
Reactive oxygen species in the neuropathogenesis of hypertension. Curr Hypertens Rep (2006) 1.40
Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab (2005) 1.39
Circulatory effects of electrical stimulation of the carotid sinus nerves in man. Circulation (1969) 1.38
Sympathetic nervous system behavior in human obesity. Neurosci Biobehav Rev (2008) 1.35
Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension (2009) 1.33
A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension (1999) 1.33
Neural mechanisms in human obesity-related hypertension. J Hypertens (1999) 1.30
Impact of chronic psychosocial stress on autonomic cardiovascular regulation in otherwise healthy subjects. Hypertension (2005) 1.30
Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension (2000) 1.28
Weight loss improves neurovascular and muscle metaboreflex control in obesity. Am J Physiol Heart Circ Physiol (2003) 1.28
Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand (2003) 1.26
Central sympathetic overactivity: maladies and mechanisms. Auton Neurosci (2009) 1.25
Exercise training restores baroreflex sensitivity in never-treated hypertensive patients. Hypertension (2007) 1.24
Simvastatin normalizes autonomic neural control in experimental heart failure. Circulation (2003) 1.24
Exercise training and sympathetic nervous system activity: evidence for physical activity dependent neural plasticity. Clin Exp Pharmacol Physiol (2007) 1.23
Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin Exp Pharmacol Physiol (2008) 1.21
Identification of higher brain centres that may encode the cardiorespiratory response to exercise in humans. J Physiol (2001) 1.21
Statin therapy restores sympathovagal balance in experimental heart failure. J Appl Physiol (1985) (2003) 1.19
Identification of neurocircuitry controlling cardiovascular function in humans using functional neurosurgery: implications for exercise control. Exp Physiol (2008) 1.16
The 'neuroadrenergic hypothesis' in hypertension: current evidence. Exp Physiol (2009) 1.16
Sympathetic outflow to muscles during treatment of hypertension with metoprolol. Hypertension (1984) 1.15
Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients. J Clin Endocrinol Metab (2009) 1.03
Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats. J Hypertens (2003) 1.02
Exercise training and sympathetic regulation in experimental heart failure. Exerc Sport Sci Rev (2004) 1.02
Sustained reduction of hypertension by deep brain stimulation. J Clin Neurosci (2009) 0.99
TREATMENT OF HYPERTENSION WITH AN IMPLANTABLE ELECTRONIC DEVICE. JAMA (1965) 0.98
Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans. J Physiol (2009) 0.98
Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol (2005) 0.97
Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. J Am Soc Nephrol (2004) 0.97
Arterial baroreceptor input contributes to long-term control of blood pressure. Curr Hypertens Rep (2006) 0.96
Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam Clin Pharmacol (2007) 0.90
An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial. J Vasc Surg (2006) 0.89
Sympathetic and baroreflex function in hypertension: implications for current and new drugs. Curr Pharm Des (2004) 0.88
Nitric oxide deficiency as a cause of clinical hypertension: promising new drug targets for refractory hypertension. JAMA (2001) 0.88
Prolonged activation of the baroreflex: a viable approach for the treatment of hypertension? Curr Hypertens Rep (2005) 0.88
Effects of short-term hypocaloric diet on sympatho-vagal interaction assessed by spectral analysis of heart rate and blood pressure variability during stress tests in obese hypertensive patients. Hypertens Res (2007) 0.87
I1-imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives. Hypertension (1998) 0.84
Haemodynamic and sympathetic effects of inhibition of nitric oxide synthase by systemic infusion of N(G)-monomethyl-L-arginine into humans are dose dependent. J Hypertens (1998) 0.82
Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. J Hypertens (1998) 0.81
Baroreflex device therapy in the treatment of hypertension. Curr Hypertens Rep (2009) 0.81
Statins and sympathetic nerve activity in heart failure. J Card Fail (2006) 0.78
Carotid sinus nerve stimulation for the treatment of intractable angina pectoris: surgical technic. Ann Surg (1970) 0.78
Rilmenidine: a clinical overview. Am J Hypertens (2000) 0.78
Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension. Clin Exp Hypertens (1997) 0.77
Simvastatin impairs exercise training adaptations. J Am Coll Cardiol (2013) 2.41
Increased muscle sympathetic nerve activity acutely alters conduit artery shear rate patterns. Am J Physiol Heart Circ Physiol (2010) 2.06
Exaggerated sympathetic and pressor responses to handgrip exercise in older hypertensive humans: role of the muscle metaboreflex. Am J Physiol Heart Circ Physiol (2010) 1.90
Skin blood flow influences near-infrared spectroscopy-derived measurements of tissue oxygenation during heat stress. J Appl Physiol (1985) (2005) 1.90
Inhibition of alpha-adrenergic vasoconstriction in exercising human thigh muscles. J Physiol (2003) 1.53
Glycopyrrolate abolishes the exercise-induced increase in cerebral perfusion in humans. Exp Physiol (2010) 1.50
Differential effect of sympathetic activation on tissue oxygenation in gastrocnemius and soleus muscles during exercise in humans. Exp Physiol (2013) 1.48
Baroreflex-mediated changes in cardiac output and vascular conductance in response to alterations in carotid sinus pressure during exercise in humans. J Physiol (2003) 1.46
Arterial baroreflex resetting during exercise: a current perspective. Exp Physiol (2005) 1.43
Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women. Arterioscler Thromb Vasc Biol (2004) 1.43
Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans. J Physiol (2010) 1.25
Central sympathetic overactivity: maladies and mechanisms. Auton Neurosci (2009) 1.25
Increased brachial artery retrograde shear rate at exercise onset is abolished during prolonged cycling: role of thermoregulatory vasodilation. J Appl Physiol (1985) (2010) 1.23
Influence of age and sex on the pressor response following a spontaneous burst of muscle sympathetic nerve activity. Am J Physiol Heart Circ Physiol (2012) 1.18
Partial blockade of skeletal muscle somatosensory afferents attenuates baroreflex resetting during exercise in humans. J Physiol (2003) 1.15
The role of α-adrenergic receptors in mediating beat-by-beat sympathetic vascular transduction in the forearm of resting man. J Physiol (2013) 1.14
Brachial artery vasodilatation during prolonged lower limb exercise: role of shear rate. Exp Physiol (2011) 1.13
Autonomic control of heart rate by metabolically sensitive skeletal muscle afferents in humans. J Physiol (2010) 1.13
Disturbed blood flow acutely induces activation and apoptosis of the human vascular endothelium. Hypertension (2013) 1.13
Spontaneous bursts of muscle sympathetic nerve activity decrease leg vascular conductance in resting humans. Am J Physiol Heart Circ Physiol (2013) 1.08
Sex differences in carotid baroreflex control of arterial blood pressure in humans: relative contribution of cardiac output and total vascular conductance. Am J Physiol Heart Circ Physiol (2011) 1.04
Middle cerebral artery flow velocity and pulse pressure during dynamic exercise in humans. Am J Physiol Heart Circ Physiol (2004) 1.01
Impact of reduced daily physical activity on conduit artery flow-mediated dilation and circulating endothelial microparticles. J Appl Physiol (1985) (2013) 1.01
Arterial baroreflex control of muscle sympathetic nerve activity in the transition from rest to steady-state dynamic exercise in humans. Am J Physiol Heart Circ Physiol (2007) 1.01
Statin therapy lowers muscle sympathetic nerve activity and oxidative stress in patients with heart failure. Am J Physiol Heart Circ Physiol (2012) 1.01
Impact of aging on conduit artery retrograde and oscillatory shear at rest and during exercise: role of nitric oxide. Hypertension (2011) 1.00
Muscle afferent contributions to the cardiovascular response to isometric exercise. Exp Physiol (2004) 0.99
Carotid baroreflex control of leg vascular conductance at rest and during exercise. J Appl Physiol (1985) (2002) 0.99
Dynamic carotid baroreflex control of the peripheral circulation during exercise in humans. J Physiol (2004) 0.99
Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans. J Physiol (2009) 0.98
Transfer function characteristics of the neural and peripheral arterial baroreflex arcs at rest and during postexercise muscle ischemia in humans. Am J Physiol Heart Circ Physiol (2009) 0.97
Central sympatholysis as a novel countermeasure for cocaine-induced sympathetic activation and vasoconstriction in humans. J Am Coll Cardiol (2007) 0.97
Carotid baroreflex control of leg vasculature in exercising and non-exercising skeletal muscle in humans. J Physiol (2004) 0.96
The interaction of central command and the exercise pressor reflex in mediating baroreflex resetting during exercise in humans. Exp Physiol (2005) 0.95
Pro-atherogenic shear rate patterns in the femoral artery of healthy older adults. Atherosclerosis (2010) 0.93
Regulation of middle cerebral artery blood velocity during dynamic exercise in humans: influence of aging. J Appl Physiol (1985) (2008) 0.92
Comparing resting skin sympathetic nerve activity between groups: caution needed. J Appl Physiol (1985) (2009) 0.91
Carotid baroreflex control of arterial blood pressure at rest and during dynamic exercise in aging humans. Am J Physiol Regul Integr Comp Physiol (2010) 0.90
The influence of central command on baroreflex resetting during exercise. Exerc Sport Sci Rev (2002) 0.90
Influence of ageing on carotid baroreflex peak response latency in humans. J Physiol (2009) 0.90
Seven days of aerobic exercise training improves conduit artery blood flow following glucose ingestion in patients with type 2 diabetes. J Appl Physiol (1985) (2011) 0.90
Influence of age on cardiac baroreflex function during dynamic exercise in humans. Am J Physiol Heart Circ Physiol (2007) 0.89
Spontaneous baroreflex measures are unable to detect age-related impairments in cardiac baroreflex function during dynamic exercise in humans. Exp Physiol (2009) 0.88
Influence of spontaneously occurring bursts of muscle sympathetic nerve activity on conduit artery diameter. Am J Physiol Heart Circ Physiol (2013) 0.88
New insights into the effects of age and sex on arterial baroreflex function at rest and during dynamic exercise in humans. Auton Neurosci (2012) 0.88
Norepinephrine increases NADPH oxidase-derived superoxide in human peripheral blood mononuclear cells via α-adrenergic receptors. Am J Physiol Regul Integr Comp Physiol (2013) 0.88
Effect of sex and ovarian hormones on carotid baroreflex resetting and function during dynamic exercise in humans. J Appl Physiol (1985) (2012) 0.87
Influence of endurance training on central sympathetic outflow to skeletal muscle in response to a mixed meal. J Appl Physiol (1985) (2010) 0.87
Regulation of middle cerebral artery blood velocity during recovery from dynamic exercise in humans. J Appl Physiol (1985) (2006) 0.85
Skin blood flow influences cerebral oxygenation measured by near-infrared spectroscopy during dynamic exercise. Eur J Appl Physiol (2013) 0.85
Enhanced open-loop but not closed-loop cardiac baroreflex sensitivity during orthostatic stress in humans. Am J Physiol Regul Integr Comp Physiol (2011) 0.85
Blood pressure regulation VIII: resistance vessel tone and implications for a pro-atherogenic conduit artery endothelial cell phenotype. Eur J Appl Physiol (2013) 0.84
Effect of muscle metaboreflex activation on carotid-cardiac baroreflex function in humans. Am J Physiol Heart Circ Physiol (2008) 0.84
Sympathetic nerve activity during non-sustained ventricular tachycardia in chronic heart failure. Int J Cardiol (2012) 0.84
Impact of age on critical closing pressure of the cerebral circulation during dynamic exercise in humans. Exp Physiol (2011) 0.83
Basis for the cardiac-related rhythm in muscle sympathetic nerve activity of humans. Am J Physiol Heart Circ Physiol (2002) 0.82
Does pulsatile and sustained neck pressure or neck suction produce differential cardiovascular and sympathetic responses in humans? Exp Physiol (2003) 0.82
Mechanism of the blood pressure--raising effect of cocaine in humans. Circulation (2002) 0.82
Cardiac and vasomotor components of the carotid baroreflex control of arterial blood pressure during isometric exercise in humans. J Physiol (2006) 0.81
Acute inactivity impairs glycemic control but not blood flow to glucose ingestion. Med Sci Sports Exerc (2015) 0.81
Exercise intensity influences cardiac baroreflex function at the onset of isometric exercise in humans. J Appl Physiol (1985) (2007) 0.80
Increases in central blood volume modulate carotid baroreflex resetting during dynamic exercise in humans. J Physiol (2007) 0.80
Adiposity-independent sympathetic activity in black men. J Appl Physiol (1985) (2010) 0.79
The neural interaction between the arterial baroreflex and muscle metaboreflex is preserved in older men. Exp Physiol (2013) 0.78
Decreased muscle sympathetic nerve activity does not explain increased vascular conductance during contralateral isometric exercise in humans. Exp Physiol (2005) 0.78
Exploring the vascular smooth muscle receptor landscape in vivo: ultrasound Doppler versus near-infrared spectroscopy assessments. Am J Physiol Heart Circ Physiol (2014) 0.76
Fractal fluctuations in breath number, period, and amplitude are independently controlled in awake, healthy humans. Conf Proc IEEE Eng Med Biol Soc (2006) 0.76
The ups and downs of assessing baroreflex function. J Physiol (2008) 0.75
Thematic reviews. Series III: Blood pressure regulation outside the comfort zone. Eur J Appl Physiol (2013) 0.75